Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
41.10
-2.64 (-6.04%)
At close: Feb 27, 2026, 4:00 PM EST
41.05
-0.05 (-0.12%)
After-hours: Feb 27, 2026, 7:04 PM EST
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.3 billion as of February 27, 2026. Its market cap has increased by 31.79% in one year.
Market Cap
4.30B
Enterprise Value
3.32B
1-Year Change
31.79%
Ranking
Category
Stock Price
$41.10
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.30B, an increase of 663.11%. That is a compound annual growth rate of 30.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.21B | -4.62% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terns Pharmaceuticals | 4.58B |
| Scholar Rock Holding | 4.52B |
| Amicus Therapeutics | 4.51B |
| TG Therapeutics | 4.40B |
| Structure Therapeutics | 4.35B |
| Erasca | 4.23B |
| ACADIA Pharmaceuticals | 4.16B |
| NewAmsterdam Pharma Company | 4.08B |